DEF 14A: Tivic Health Systems Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
Proxy Statement
Tivic Health Systems announces its 2024 Annual Meeting of Stockholders to be held virtually on August 9, 2024, featuring proposals for director elections, equity incentive plan amendments, and auditor ratification.
Summary
- Tivic Health Systems, Inc. will hold its 2024 Annual Meeting of Stockholders on August 9, 2024, at 10:00 a.m. Pacific Time, in a virtual format.
- Stockholders of record as of June 17, 2024, are entitled to notice of and to vote at the Annual Meeting.
- The meeting will address the election of two Class III directors, the approval of amendments to the 2021 Equity Incentive Plan, the ratification of the selection of Rosenberg Rich Baker Berman, P.A. as the independent registered public accounting firm, and the approval of adjourning the meeting if necessary to solicit additional proxies.
- The Board recommends voting FOR each of the Class III director nominees and FOR Proposals 2, 3, and 4.
- The company is providing access to proxy materials primarily electronically via the Internet, with a Notice of Internet Availability of Proxy Materials mailed on or about June 28, 2024.
- As of the record date, there were 6,183,592 shares of Common Stock issued and outstanding, held by approximately 98 stockholders of record.
Sentiment
Score: 7
Explanation: The document is primarily informational and procedural, with a positive outlook on incentivizing employees and maintaining good corporate governance. The Board's recommendations suggest confidence in the proposals.
Positives
- The virtual format of the Annual Meeting provides a convenient experience for all stockholders.
- Electronic delivery of proxy materials expedites receipt and reduces costs.
- The Board is actively recommending votes on key proposals, indicating a clear direction for stockholders.
- The proposed amendment to the 2021 Equity Incentive Plan aims to attract, retain, and incentivize key personnel.
Negatives
- Abstentions on Proposals 2, 3, and 4 will be treated as votes AGAINST the proposals.
- If the stockholders do not approve the A&R 2021 Plan, the company's ability to recruit and retain talent necessary to execute business plans will be damaged.
Risks
- Failure to secure sufficient votes for any of the proposals may necessitate adjournment of the Annual Meeting.
- If the proposed amendments to the 2021 Equity Incentive Plan are not approved, the company's ability to attract and retain key personnel could be negatively impacted.
- The company's reliance on electronic delivery of proxy materials may exclude stockholders without internet access.
Future Outlook
The company intends to announce preliminary voting results at the Annual Meeting and publish final results in a Current Report on Form 8-K within four business days from the Annual Meeting.
Management Comments
- Our Board has carefully reviewed and considered the foregoing proposals, and has concluded that each proposal is in the best interests of the Company and its stockholders.
- Therefore, our Board has approved each proposal and recommends that you vote FOR each of the Class III director nominees and For each of Proposals 2, 3 and 4.
Industry Context
The use of a virtual format for the annual meeting aligns with a growing trend in corporate governance to enhance accessibility and reduce costs. The proposals reflect standard corporate practices for maintaining governance and incentivizing employees.
Comparison to Industry Standards
- The virtual annual meeting format is increasingly common, with companies like Apple and Alphabet also adopting this approach for accessibility.
- The proposed amendments to the equity incentive plan are similar to those seen in other growth-stage companies to attract and retain talent, with share reserves typically ranging from 10-20% of outstanding shares, putting Tivic's proposed 16% within a reasonable range.
- Ratification of the independent auditor is a standard practice, comparable to actions taken by companies like Medtronic and Boston Scientific.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director (Class I) | Karen Drexler | Christina Valauri | July 1, 2024 | To fill a vacancy in the Class I class of directors of the Board. |
| Member of the Compensation Committee | Karen Drexler | Christina Valauri | July 1, 2024 | Board appointment. |
| Member of the Audit and Risk Committee | Karen Drexler | Christina Valauri | July 1, 2024 | Board appointment. |
| Member of the Nominations and Corporate Governance Committee | Karen Drexler | Christina Valauri | July 1, 2024 | Board appointment. |
| Chairperson of the Nominations and Corporate Governance Committee | Karen Drexler | Christina Valauri | July 1, 2024 | Board appointment. |
| Director | Karen Drexler | NA | September 30, 2024 | Resignation. |
| Member of the Compensation Committee | Karen Drexler | NA | September 30, 2024 | Resignation. |
| Member of the Audit and Risk Committee | Karen Drexler | NA | September 30, 2024 | Resignation. |
| Member of the Nominations and Corporate Governance Committee | Karen Drexler | NA | September 30, 2024 | Resignation. |
Stakeholder Impact
- Approval of the equity incentive plan amendment could positively impact employees by providing additional incentives.
- Ratification of the auditor ensures continued financial oversight and transparency for shareholders.
- Election of directors shapes the leadership and strategic direction of the company, impacting all stakeholders.
Next Steps
- Stockholders are urged to vote by telephone, mail, fax, or on the Internet using the instructions provided in the Notice.
- The company will announce preliminary voting results at the Annual Meeting and publish final results in a Current Report on Form 8-K.
Key Dates
| Date | Description |
|---|---|
| June 17, 2024 | Record date for determining stockholders entitled to notice of and to vote at the Annual Meeting. |
| June 28, 2024 | Approximate date of mailing the Notice of Internet Availability of Proxy Materials. |
| August 9, 2024 | Date of the 2024 Annual Meeting of Stockholders. |
Keywords
Annual Meeting, Proxy Statement, Stockholders, Board of Directors, Equity Incentive Plan, Director Election, Auditor Ratification, Tivic Health Systems
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.